Barrios V - Search Results

1

Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.

Barrios V, Amabile N, Paganelli F, Chen JW, Allen C, Johnson-Levonas AO, Massaad R, Vandormael K. Barrios V, et al. Int J Clin Pract. 2005 Dec;59(12):1377-86. doi: 10.1111/j.1368-5031.2005.00714.x. Int J Clin Pract. 2005. PMID: 16351668 Clinical Trial.

2

Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study.

Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderón A; LAURA Investigators. Barrios V, et al. Among authors: barrios l. Int J Clin Pract. 2006 Nov;60(11):1364-70. doi: 10.1111/j.1742-1241.2006.01176.x. Int J Clin Pract. 2006. PMID: 17073834 Free PMC article.

3

[Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study].

Barrios V, Escobar C, Llisterri JL, Calderón A, Alegría E, Muñiz J, Matalí A. Barrios V, et al. Rev Clin Esp. 2007 Apr;207(4):172-8. doi: 10.1157/13101845. Rev Clin Esp. 2007. PMID: 17475179 Spanish.

4

High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.

Barrios V, Escobar C, de la Figuera M, Honorato J, Llisterri JL, Segura J, Calderón A. Barrios V, et al. Int J Clin Pract. 2008 May;62(5):723-8. doi: 10.1111/j.1742-1241.2008.01736.x. Epub 2008 Mar 17. Int J Clin Pract. 2008. PMID: 18355238 Free PMC article. Clinical Trial.

5

[Diabetes mellitus in hypertensive population attended in Primary Care in Spain. Blood pressure and lipid control rates].

Escobar C, Barrios V, Calderón A, Llisterri JL, García S, Rodríguez-Roca GC, Matalí A. Escobar C, et al. Among authors: barrios v. Rev Clin Esp. 2007 May;207(5):221-7. doi: 10.1157/13102313. Rev Clin Esp. 2007. PMID: 17504665 Spanish.

6

[Optimal cholesterol levels in patients in real-life. A systematic review].

Escobar C, Barrios V, Pérez de Isla L. Escobar C, et al. Among authors: barrios v. Semergen. 2018 Jan-Feb;44(1):42-49. doi: 10.1016/j.semerg.2017.08.006. Epub 2017 Nov 16. Semergen. 2018. PMID: 29153337 Review. Spanish.

7

[Tolerability and efficiency of a new transdermic nitroglycerin patch in outpatients with chronic stable angina. The PATRICH Trial].

Barrios V, Fernández E, Campuzano R, Peña G; PATRICH study group. Barrios V, et al. Rev Clin Esp. 2002 Jul;202(7):379-84. doi: 10.1016/s0014-2565(02)71085-0. Rev Clin Esp. 2002. PMID: 12139821 Clinical Trial. Spanish.

8

Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.

Barrios V, Escobar C, Calderón A, Echarri R, González-Pedel V, Ruilope LM; CONTROLRISK Investigators. Barrios V, et al. J Hum Hypertens. 2007 Jun;21(6):479-85. doi: 10.1038/sj.jhh.1002167. Epub 2007 Feb 22. J Hum Hypertens. 2007. PMID: 17314997 Clinical Trial.

9

Calcium channel blocker-based combination therapy. The best approach in the treatment of high-risk hypertension?

Escobar C, Barrios V. Escobar C, et al. Among authors: barrios v. Int J Clin Pract. 2008 May;62(5):670-2. doi: 10.1111/j.1742-1241.2008.01728.x. Int J Clin Pract. 2008. PMID: 18412928 No abstract available.

10

Renal dysfunction and heart failure.

Escobar C, Echarri R, Barrios V. Escobar C, et al. Among authors: barrios v. Panminerva Med. 2010 Mar;52(1):67-78. Panminerva Med. 2010. PMID: 20228727 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters